177Lu-DansyI-PSMA (LNC1011)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-DansyI-PSMA (LNC1011), covering 2025-04-01 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]